In addition to the direct activity of SB105-A10 on the envelope glycoproteins, the pre-attachment assay indicated that the dendrimer might inhibit HIV infection through direct binding with molecular targets on the cell membrane. This evidence concerns the gene ERVW-1 and HIV infectious disease.